These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


359 related items for PubMed ID: 6381335

  • 21. Species similarities and differences in pharmacokinetics.
    Lin JH.
    Drug Metab Dispos; 1995 Oct; 23(10):1008-21. PubMed ID: 8654187
    [Abstract] [Full Text] [Related]

  • 22. Role of binding in distribution of furosemide: where is nonrenal clearance?
    Branch RA.
    Fed Proc; 1983 Apr; 42(6):1699-702. PubMed ID: 6832389
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of maturation on drug disposition in pediatric patients.
    Stewart CF, Hampton EM.
    Clin Pharm; 1987 Jul; 6(7):548-64. PubMed ID: 3319364
    [Abstract] [Full Text] [Related]

  • 27. [Pharmacotherapy in severe liver failure].
    Hruby K, Kleinberger G.
    Leber Magen Darm; 1982 Oct; 12(5):188-92. PubMed ID: 7182698
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL.
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [Abstract] [Full Text] [Related]

  • 30. Consideration of sheep as a minor species: comparison of drug metabolism and disposition with other domestic ruminants.
    Short CR.
    Vet Hum Toxicol; 1993 Nov; 35 Suppl 2():40-56. PubMed ID: 8236767
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical pharmacokinetics of the salicylates.
    Needs CJ, Brooks PM.
    Clin Pharmacokinet; 1985 Nov; 10(2):164-77. PubMed ID: 3888490
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Changes in pharmacokinetics in elderly patients].
    Nadai M, Katoh M.
    Nihon Rinsho; 2013 Jun; 71(6):999-1003. PubMed ID: 23855202
    [Abstract] [Full Text] [Related]

  • 39. Influence of hepatic and renal disorders on the pharmacokinetics of sulfachloropyridacine.
    Mariño EL, Dominguez-Gil A, Tabernero JM, Macias JG.
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):10-4. PubMed ID: 7364528
    [Abstract] [Full Text] [Related]

  • 40. [Pharmacokinetic changes in obesity].
    Girardin E, Bruguerolle B.
    Therapie; 1993 Jan; 48(4):397-402. PubMed ID: 8128423
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.